Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4352 USD | +6.16% | -8.32% | -97.62% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.99M |
---|---|---|---|---|---|
Net income 2024 * | -26M | Net income 2025 * | -34M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.08
x | P/E ratio 2025 * |
-0.09
x | Employees | 8 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 100% |
Latest transcript on Panbela Therapeutics, Inc.
1 day | +6.16% | ||
1 week | +3.64% | ||
Current month | -35.03% | ||
1 month | -20.85% | ||
3 months | -67.51% | ||
6 months | -97.23% | ||
Current year | -97.62% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 0.4352 | +6.16% | 70,416 |
24-04-26 | 0.41 | -6.82% | 48,233 |
24-04-25 | 0.44 | +7.29% | 25,779 |
24-04-24 | 0.4101 | -2.36% | 14,382 |
24-04-23 | 0.42 | -11.54% | 63,942 |
Delayed Quote OTC Markets, April 29, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-97.62% | 1.99M | |
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |
- Stock Market
- Equities
- SNBP Stock